Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP393493.RA4u-bF-oMS5PgZGX4Z0CdymwjYqgDXdZIkvJdPoxxT9Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP393493.RA4u-bF-oMS5PgZGX4Z0CdymwjYqgDXdZIkvJdPoxxT9Y130_assertion type Assertion NP393493.RA4u-bF-oMS5PgZGX4Z0CdymwjYqgDXdZIkvJdPoxxT9Y130_head.
- NP393493.RA4u-bF-oMS5PgZGX4Z0CdymwjYqgDXdZIkvJdPoxxT9Y130_assertion description "[Targeted disruption of FANCC and FANCG in human cancer provides a preclinical model for specific therapeutic options.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP393493.RA4u-bF-oMS5PgZGX4Z0CdymwjYqgDXdZIkvJdPoxxT9Y130_provenance.
- NP393493.RA4u-bF-oMS5PgZGX4Z0CdymwjYqgDXdZIkvJdPoxxT9Y130_assertion evidence source_evidence_literature NP393493.RA4u-bF-oMS5PgZGX4Z0CdymwjYqgDXdZIkvJdPoxxT9Y130_provenance.
- NP393493.RA4u-bF-oMS5PgZGX4Z0CdymwjYqgDXdZIkvJdPoxxT9Y130_assertion SIO_000772 16762635 NP393493.RA4u-bF-oMS5PgZGX4Z0CdymwjYqgDXdZIkvJdPoxxT9Y130_provenance.
- NP393493.RA4u-bF-oMS5PgZGX4Z0CdymwjYqgDXdZIkvJdPoxxT9Y130_assertion wasDerivedFrom befree-20150227 NP393493.RA4u-bF-oMS5PgZGX4Z0CdymwjYqgDXdZIkvJdPoxxT9Y130_provenance.
- NP393493.RA4u-bF-oMS5PgZGX4Z0CdymwjYqgDXdZIkvJdPoxxT9Y130_assertion wasGeneratedBy ECO_0000203 NP393493.RA4u-bF-oMS5PgZGX4Z0CdymwjYqgDXdZIkvJdPoxxT9Y130_provenance.